Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Michigan Kristalose Trial
NCT05061992Phase 3Completed
- Sponsor
- University of Michigan
- Start
- Nov 2021
- Primary completion
- Nov 2022
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of lactulose in Cirrhosis (2 arms), sponsored by University of Michigan. Primary endpoint: Short Form-8 Health Survey at 28 days. Started Nov 2021; status: completed.
02
Drugs
lactulose
03
Conditions
Cirrhosis
Beyond the preview
Go deeper on NCT05061992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05061992.